The prevalence of thoracic aortic aneurysms in patients with abdominal aortic aneurysms
Investigating the prevalence of thoracic aortic aneurysms in patients with abdominal aortic aneurysms in order to improve clinical practice and patient outcomes
- Hospital – Speciality: Manchester Royal Infirmary – Vascular surgery
- Study type: Study limited to working with data
Summary
An aortic aneurysm is characterised as a ballooning of the main blood vessel in the body – the aorta. A ruptured aneurysm remains one of the leading causes of premature death in the UK, typically because the disorder is symptomless and remains undetected. Currently, an abdominal aortic aneurysm (AAA) surveillance program exists which invites those at risk for ultrasound screening. However, while it is possible for those with a AAA to have a further aneurysm in the section of the aorta within the chest (thoracic aortic aneurysm (TAA)), the percentage of these patients within the UK is unknown and TAAs are not routinely screened for. This study aims to determine:
- the percentage of patients with a AAA who also have a TAA within the Manchester University NHS Foundation Trust
- whether it is beneficial to screen those with a AAA for a TAA
- groups who may be more at risk of having both these types of aneurysms.
By providing a greater understanding of the rate of simultaneous occurrence of both aneurysm types, this study could provide a foundation on which a TAA surveillance program could be built, providing a significant survival advantage for those with aneurysms.
Participant group
Patients diagnosed with an AAA between 2011 and 2021 who have been placed on the AAA surveillance program at MFT and undergone a thoracic CT
Study open date and expected length
Opened: August 2024
Expected end date: February 2025
Results
Pending – this study is still active.
Contact details
Telephone number: 0161 64312
Email address: holly.watson@mft.nhs.uk
- IRAS number: 338578
